|
⚲
|
| Trigemina Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001385405 |
| Sale | 2009-12-08 ($1.0 M Offered, $0.3 M Sold) |
| Fund | |
| Phone | 6503036140 |
| Address | 809B Cuesta Drive Ste 109 Mountain View, 94040 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Mark Benham | |
| Daniel Jacobs | |
| Mark McCamish | |
| Urs Holzle |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Hainan Runming Biotechnology Co., Ltd.
✚
|
0.0 | |
|
Hainer Victor K
✚
|
0.0 | |
|
H&A Investor LP LLC
✚
|
0.0 | |
|
Haiti Green, LLC
✚
|
0.0 | |
|
Haitou U.S. Fund, L.P. - Series B
✚
|
0.0 | |
|
Haitou Venture Fund I LP
✚
|
0.0 | |
|
HAI Vellum Wellness Co-Invest, LLC
✚
|
0.0 | |
|
Halcyon European Credit Opportunities Fund LP
✚
|
0.0 | |
|
Halcyon European Credit Opportunities Fund Offshore Ltd.
✚
|
0.0 | |
|
Hague John
✚
|
0.0 |